PEG-Coated MnZn Ferrite Nanoparticles with Hierarchical Structure as MRI Contrast Agent.

Sedigheh Cheraghali, Ghasem Dini, Isabella Caligiuri, Michele Back, Flavio Rizzolio
Author Information
  1. Sedigheh Cheraghali: Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, 30172 Venice, Italy.
  2. Ghasem Dini: Department of Nanotechnology, Faculty of Chemistry, University of Isfahan, Isfahan 81746-73441, Iran. ORCID
  3. Isabella Caligiuri: Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
  4. Michele Back: Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, 30172 Venice, Italy. ORCID
  5. Flavio Rizzolio: Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, 30172 Venice, Italy. ORCID

Abstract

In this work, MnZn ferrite nanoparticles with hierarchical morphology were synthesized hydrothermally, and their surface characteristics were improved by the PEGylation process. In vitro MRI studies were also conducted to evaluate the ability of the synthesized nanoparticles as a contrast agent. All results were compared with those obtained for MnZn ferrite nanoparticles with normal structure. Microstructural evaluations showed that in ferrite with hierarchical morphology, the spherical particles with an average size of ~20 nm made a distinctive structure consisting of rows of nanoparticles which is a relatively big assembly like a dandelion. The smaller particle size and dandelion-like morphology led to an increase in specific surface area for the hierarchical structure (~69 m/g) in comparison to the normal one (~30 m/g) with an average particle size of ~40 nm. In vitro MRI, cytotoxicity and hemocompatibility assays confirmed the PEG-coated MnZn ferrite nanoparticles with hierarchical structure synthesized in the current study can be considered as an MRI contrast agent.

Keywords

References

  1. Nanomaterials (Basel). 2017 Aug 29;7(9): [PMID: 28850089]
  2. Mater Sci Eng C Mater Biol Appl. 2020 Feb;107:110314 [PMID: 31761184]
  3. Adv Colloid Interface Sci. 2019 Mar;265:29-44 [PMID: 30711796]
  4. Acta Biomater. 2013 May;9(5):6421-30 [PMID: 23321305]
  5. Angew Chem Int Ed Engl. 2009;48(7):1234-8 [PMID: 19137514]
  6. ACS Appl Mater Interfaces. 2015 Jan 21;7(2):1327-33 [PMID: 25539822]
  7. Future Sci OA. 2017 Sep 18;5(1):FSO235 [PMID: 30652014]
  8. Ceram Int. 2020 Jul;46(10):15740-15763 [PMID: 32292223]
  9. Nat Med. 2007 Jan;13(1):95-9 [PMID: 17187073]
  10. Int J Nanomedicine. 2015 Mar 06;10:1727-41 [PMID: 25834422]
  11. Nanomaterials (Basel). 2021 Feb 09;11(2): [PMID: 33572244]
  12. Int J Pharm. 2012 Aug 20;433(1-2):129-41 [PMID: 22579990]
  13. Magn Reson Imaging. 2016 Dec;34(10):1394-1398 [PMID: 27693607]
  14. Nanotechnology. 2016 Jun 24;27(25):255702 [PMID: 27184442]
  15. Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):28-51 [PMID: 26456916]

Word Cloud

Created with Highcharts 10.0.0nanoparticlesMnZnferritehierarchicalMRIstructuremorphologysynthesizedcontrastagentsizesurfacePEGylationprocessvitronormalaveragenmparticlem/gworkhydrothermallycharacteristicsimprovedstudiesalsoconductedevaluateabilityresultscomparedobtainedMicrostructuralevaluationsshowedsphericalparticles~20madedistinctiveconsistingrowsrelativelybigassemblylikedandelionsmallerdandelion-likeledincreasespecificarea~69comparisonone~30~40cytotoxicityhemocompatibilityassaysconfirmedPEG-coatedcurrentstudycanconsideredPEG-CoatedFerriteNanoparticlesHierarchicalStructureContrastAgentnanostructure

Similar Articles

Cited By